Endocannabinoid System Clinical Research: Minder Mobile Mental Health RCT
This randomized controlled trial evaluates the effectiveness minder mobile mental health app designed for university students. The study focuses on improving mental health and substance use outcomes during the college transition. Results provide evidence…
Cannabinoid Clinical Trials: Insomnia Study with Sleep EEG
This cannabinoid clinical trials insomnia study examined the effects of THC and CBD on sleep in adults with diagnosed insomnia. The trial used high-density EEG to assess sleep architecture changes. Results showed altered sleep patterns without improving…
Therapeutically Motivated Cannabis Use for Anxiety: Research Findings
Therapeutically motivated cannabis use anxiety research reveals that flower and edible products differ in their effects on anxiety. The THC-to-CBD ratio plays a crucial role in symptom relief. Patients should discuss cannabis product types with…
Adolescent Psychosocial Risk Factors in Health Research
This study highlights adolescent psychosocial risk factors as predictors of long-term health outcomes. Early identification of these factors is crucial for intervention. The findings emphasize the importance of addressing adolescent vulnerabilities to…
Clinical Insights on Cannabinoid Trials for PTSD and Substance Use
Cannabinoid clinical trials PTSD and substance use data provide critical insights into treatment outcomes for patients with co-occurring disorders. These trials show trauma-focused therapies remain effective regardless of cannabis use. Understanding this…
Cannabinoid Clinical Trials: Mobile Mental Health RCT
This mobile mental health intervention RCT tested the Minder app designed for university students. The trial assessed improvements in mental health and substance use outcomes. Results provide evidence for scalable digital tools in student mental health…
What kind of tree is this?
Your dispensary’s favorite diagnostic question: pretty sure that’s an indica, sativa, or hybrid, but honestly the cannabinoid profile matters more than the botanical taxonomy. Via r/trees Further Reading Cannabis Policy WirePolicy Watch: 20…
Hello everyone, greetings from Morocco
When your patient’s terpene profile discussion gets a little too geographically specific for the clinic notes. Via r/trees Further Reading Research DigestAM Policy Update: March 11, 2026 Evidence WatchCannabinoid Clinical Trials in Athlete Mental…
Alabama Medical Marijuana Sales Near Launch After Years Of Delay
Alabama medical marijuana patient access is poised to start after a prolonged regulatory delay. This launch marks a major shift in patient availability of cannabis therapeutics in Alabama. Clinicians should prepare for increased patient inquiries and…
Cannabis Market Sales Projections and Regulatory Insights
Cannabis market sales projections highlight a $2.6 billion annual figure for New York in 2026. The evolving cannabis regulatory landscape affects cannabinoid product availability. Clinicians must navigate these changes carefully to support patient care.